Cytosorbents (CTSO) Reports In-Line Q3 EPS

Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $3.45 million versus the consensus estimate of $3.86 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• INVO Fertility (IVF) Tops Q2 EPS by 105c